Skip to main content
64°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biomea Fusion Inc
(NQ:
BMEA
)
7.610
+0.730 (+10.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biomea Fusion Inc
< Previous
1
2
3
4
5
6
7
Next >
Biomea Fusion Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
March 28, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Nasdaq Dips 90 Points; Walgreens Posts Upbeat Q2 Results
March 28, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 90 points on Tuesday. The Dow traded down 0.21% to 32,362.74 while the NASDAQ fell 0.77% to 11,678.39. The...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 28, 2023
Via
Benzinga
Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 28, 2023
Gainers
Via
Benzinga
Where Biomea Fusion Stands With Analysts
March 28, 2023
Via
Benzinga
Stocks Mixed After Upbeat Consumer Confidence Data
March 28, 2023
The Dow Jones Industrial Average managed to swing into positive territory this afternoon, though the S&P 500 Index and Nasdaq Composite Index are still sitting in the red.
Via
Talk Markets
Dow Rises 50 Points; Harmony Biosciences Shares Plunge
March 28, 2023
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 50 points on Tuesday. The Dow traded up 0.16% to 32,484.24 while the NASDAQ fell 0.75% to 11,681.12. The S&P 500, also...
Via
Benzinga
Biomea Fusion (NASDAQ: BMEA) Reports Positive Initial Findings From the COVALENT-111 Phase II Study of BMF-219 for the Treatment of Type 2 Diabetes
March 28, 2023
Biomea Fusion, Inc. (NASDAQ: BMEA) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research, discovery and
Via
Spotlight Growth
What's Driving Biomea Fusion Shares Higher Today?
March 28, 2023
Biomea Fusion Inc (NASDAQ: BMEA) shares are trading higher Tuesday after the company announced data from the initial cohorts of the ongoing Phase II study of BMF-219 in patients with
Via
Benzinga
Why Shares of Biomea Fusion Jumped This Week
January 20, 2023
The company launched its second trial this year for its lead therapy.
Via
The Motley Fool
Analyst Expectations for Biomea Fusion's Future
January 13, 2023
Via
Benzinga
Nasdaq Down Over 50 Points; US Goods Trade Deficit Widens Slightly
March 28, 2023
U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.01% to 32,436.22 while the NASDAQ fell...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 28, 2023
Via
Benzinga
Biomea Fusion Announces Positive Data from Initial Cohorts of Ongoing Phase II Study (COVALENT-111) of BMF-219 in Patients with Type 2 Diabetes; 100 mg Cohort 3 Demonstrated an 89% Response Rate and 1% Median Reduction in HbA1c at Day 28
March 28, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion to Host Conference Call and Webcast to Discuss Initial Phase II Clinical Data for BMF-219 in Subjects with Type 2 Diabetes on March 28th, 2023 at 8:30 a.m. ET
March 23, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Rise in Biotech Innovations Generating Hope as Pancreatic Cancer Survival Rates Climb
March 14, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 14, 2023 – USA News Group – Optimism is on the rise as the American Cancer Society is reporting that the five-year survival...
Via
FinancialNewsMedia
Exposures
Product Safety
Biomea Fusion To Participate In Upcoming Investor Events
March 02, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
February 24, 2023
Via
Benzinga
Biomea Fusion Doses First Patient in Phase I/Ib Clinical Trial (COVALENT-102) of BMF-219 in KRAS Mutant Solid Tumors
January 17, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
US Stocks Edge Lower; Bank of America Profit Tops Views
January 13, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping around 50 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 13, 2023
Via
Benzinga
Biomea Fusion to Present at 41st Annual J.P. Morgan Healthcare Conference and Highlight 2023 Corporate Milestones
January 09, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Announces Dosing of First Patient with Type 2 Diabetes in the United States in Ongoing Phase I/II (COVALENT-111) Study of BMF-219
January 04, 2023
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Announces FDA Clearance of Investigational New Drug (IND) Application for Covalent Menin Inhibitor BMF-219 in Type 2 Diabetes
December 14, 2022
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Presents at the 2022 ASH Annual Meeting Preclinical Data on BMF-500 Supporting its Potential as the Most Potent and Selective FLT3 Inhibitor to Date
December 12, 2022
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Is Ardelyx is A Buy After Slip in Early 2022
November 21, 2022
Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them
Via
MarketBeat
Exposures
Product Safety
Biomea Fusion to Participate in Piper Sandler 34th Annual Healthcare Conference
November 11, 2022
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion Reports Third Quarter 2022 Financial Results and Business Highlights
November 07, 2022
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Biomea Fusion to Present Preclinical Data for BMF-500, an Investigational Oral Covalent FLT3 Inhibitor, at the 64th American Society of Hematology (ASH) Annual Meeting
November 03, 2022
From
Biomea Fusion, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.